Epstein-Barr Virus, Multiple Sclerosis, Latent, Pathogenesis, Immune System Share and Cite: Pandey, B. (2024) The Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis. Open Access ...

As with other disease states, biomarkers that can provide value across diagnosis, prognosis, and treatment response, have ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with ...

the possible correlation between virus infections and multiple sclerosis (MS) pathogenesis is based on two main hypotheses: the 'prevalence hypothesis' and the 'poliomyelitis hypothesis'.

In a recent study, Alistipes onderdonkii, had a positive association with cerebral leptomeningeal enhancement in patients ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

2 Second, scientists investigating MS pathogenesis confirmed that the natural history of MS could be altered with an immunomodulating approach, generating a rationale for the clinical use of ...